Safety concerns about breast implants persistBMJ 2003; 327 doi: http://dx.doi.org/10.1136/bmj.327.7421.947 (Published 23 October 2003) Cite this as: BMJ 2003;327:947
- Ray Moynihan
The US Food and Drug Administration will continue to evaluate the safety of silicone breast implants before making a decision on reapproval, despite a recent recommendation from its advisers.
After a marathon two day hearing last week, the FDA's advisory panel on plastic surgery voted to end the 10 year moratorium on silicone implants for breast enlargement, though safety concerns saw the panel spilt, with a vote of nine to six in favour. …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial